Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
- 1 March 1998
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 137 (1) , 1-11
- https://doi.org/10.1016/s0021-9150(97)00266-9
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approachCurrent Opinion in Lipidology, 1996
- Identification and Characterization of a New Human Gene (APOC4) in the Apolipoprotein E, C-I, and C-II Gene LocusGenomics, 1995
- The Apolipoprotein C2-Linked (Acl) Gene: A New Gene within the Mouse Apolipoprotein e-c1-c2 Gene ClusterGenomics, 1994
- Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.Journal of Clinical Investigation, 1994
- Evolutionary Conservation of the Mouse Apolipoprotein e-c1-c2 Gene Cluster: Structure and Genetic Variability in Inbred MiceGenomics, 1993
- Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic MiceScience, 1990
- Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4Biochemical and Biophysical Research Communications, 1989
- Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit.Proceedings of the National Academy of Sciences, 1985
- Type III Hyperlipoproteinemia Associated with Apolipoprotein E DeficiencyScience, 1981
- Inbred Mice and their Hybrids as an Animal Model for Atherosclerosis ResearchPublished by Springer Nature ,1976